GHK-Cu
A copper-binding peptide your body naturally produces — and one of the few peptides with real human evidence for skin rejuvenation. Topical serums are the practical entry point; injectable is more experimental.
GHK-Cu is a naturally occurring tripeptide in your blood that binds copper and activates over 4,000 genes involved in tissue repair. Your levels decline with age — from ~200 ng/mL at 20 to ~80 ng/mL by 60. Topical application has solid human evidence for skin rejuvenation; injectable use is more experimental.
Often used by: People interested in evidence-based anti-aging skincare, those with thinning hair, and advanced users exploring systemic peptide effects.
Dive deeper into the researchCommon side effects
- Mild skin irritation if used with acidic serums (vitamin C)
- Injection site reactions (if using injectable form)
- Skin purging in the first 1–2 weeks with topical use
What does GHK-Cu do?
GHK-Cu (glycyl-histidyl-lysine copper chelate) is found naturally in your blood plasma. It was originally discovered as a liver regeneration factor. Its claim to fame is breadth: gene chip studies show it modulates roughly 4,000 genes — upregulating repair, collagen production, and antioxidant defence, while downregulating inflammation and degeneration.
For your skin specifically, it stimulates fibroblasts to produce type I and III collagen, increases hyaluronic acid production, and reduces TGF-β1 (the driver of scar tissue). The net result: more organised, healthy collagen rather than disorganised fibrosis.
The copper component isn't decorative — it serves as a cofactor for enzymes like lysyl oxidase (collagen cross-linking) and superoxide dismutase (antioxidant defence).
Who uses it?
- Anti-aging skincare — one of the better-evidenced cosmetic peptides available
- Hair thinning — scalp application may stimulate follicle proliferation (moderate evidence)
- Post-procedure recovery — after microneedling, laser, or chemical peels
- Advanced users — injectable for systemic anti-inflammatory and repair effects (limited human data)
What to know before trying
For most people, a quality topical GHK-Cu serum (0.1–1%) applied daily is the most evidence-supported, accessible, and safe approach. Injectable use requires physician supervision and carries unknown systemic risks for relatively modest additional benefit over topical for skin applications.
Topical application: Apply 2–4 drops to clean skin once or twice daily. Separate from acidic-pH products (like vitamin C serums) to prevent copper complex dissociation.
Results timeline: Expect gradual improvement over 8–12 weeks of consistent use. Skin density and fine line reduction are the most commonly reported effects.
Topical vs injectable: Topical has better human evidence and a well-established safety profile. Injectable delivers systemic effects (anti-inflammatory, liver protection) but with much less human data.
Want to track if your peptide protocol is working?
eterni connects your labs, supplements, and retests — so you can see real data, not just guesswork.
Get early accessFrequently Asked Questions
Does GHK-Cu really work for skin?
Yes, with good confidence. Multiple controlled human studies show increased collagen density, reduced wrinkle depth, and improved skin elasticity with topical GHK-Cu. It’s among the better-evidenced cosmetic peptides. Results are real but gradual — typically 8–12 weeks of consistent use.
GHK-Cu topical vs injectable — what is the difference?
Topical acts locally in the dermis — well-studied for collagen stimulation and skin repair. Injectable delivers the peptide systemically for broader effects including liver regeneration and systemic anti-inflammation, but with minimal human evidence compared to topical. For skin aging, topical is both more evidence-based and safer.
What does GHK-Cu do for hair?
Several studies show GHK-Cu can increase follicle size and vascularisation. It’s not as potent as minoxidil or finasteride for significant hair loss, but represents a reasonable adjunct. Scalp application via serum is the practical route.
Is GHK-Cu available in India?
Yes — topical copper peptide serums are commercially available through skincare brands in India. These are legal cosmetic products. Injectable GHK-Cu is available through research chemical suppliers in the usual unregulated grey area.
How it works in your body
GHK-Cu directly activates fibroblasts to upregulate type I and III collagen, fibronectin, and glycosaminoglycans including hyaluronic acid. It reduces TGF-β1 (the scar tissue driver), promotes VEGF-mediated blood vessel growth, and upregulates antioxidant enzymes (SOD, catalase). The copper component serves as an essential cofactor for multiple enzymes involved in collagen cross-linking and energy metabolism.
The gene expression data is remarkable in breadth — modulating ~4,000 genes toward a more regenerative profile — but gene expression changes don’t automatically translate to functional tissue improvements.
What the studies show
- Skin: Multiple double-blind controlled studies showing increased skin density, reduced wrinkle depth, improved elasticity
- vs Retinoic acid: Head-to-head studies show GHK-Cu competes favourably with fewer side effects (less irritation)
- Wound healing: Faster healing and better scar quality vs control in both normal and aged skin
- Hair: Increased follicle size and vascularisation in scalp application studies (moderate evidence)
What to monitor
For topical use, monitoring isn’t typically necessary — assess results visually and through skin quality over 8–12 weeks. For injectable use, consider baseline copper levels and liver function tests.
Side effects & safety
GHK-Cu’s safety profile depends heavily on the route of administration:
- Topical — skin irritation — uncommon but possible, especially if combined with acidic products. Less irritating than retinoids.
- Topical — initial purging — some users experience a brief period of skin adjustment in the first 1–2 weeks.
- Topical — copper sensitivity — rare, but people with known copper sensitivity should patch test first.
- Injectable — injection site reactions — standard redness and tenderness.
- Injectable — unknown systemic effects — human data for systemic GHK-Cu dosing is very limited. Long-term safety is not established.
- Copper overload concern — at topical doses, copper absorption is minimal. At injectable doses, copper levels could theoretically rise. People with Wilson’s disease should avoid it entirely.
Who should avoid it: People with Wilson’s disease or copper metabolism disorders, those with known copper sensitivity (topical), and anyone using injectable without physician supervision.
Know what's working. Know what's not.
eterni connects your lab results, supplements, and retests — so you can see the trajectory, not just a snapshot.
Join the waitlist